Advanced Clinical Announces New Executive Director Of Regulatory Affairs

ADVANCED CLINICAL ANNOUNCES NEW EXECUTIVE DIRECTOR OF REGULATORY AFFAIRS

Advanced Clinical introduces Eman Albazzaz as its new Executive Director of Regulatory Affairs.

DEERFIELD, IL (July 12, 2011) - Advanced Clinical, a leading provider of clinical research solutions, today announced an addition to its leadership team: Eman Albazzaz has been hired as Executive Director of Regulatory Affairs to lead Advanced Clinical's regulatory and pharmacovigilance efforts.

Ms. Albazzaz is an accomplished regulatory affairs and pharmacovigilance executive with a history of successfully leading global regulatory strategy, risk-management strategy, and pharmacovigilance. An expert in systems thinking and execution of high-quality management processes, Ms. Albazzaz formulates vision, builds organizations, and provides guidance in the establishment of effective policies, procedures, and global training programs.

Ms. Albazzaz is known for her global pharmaceutical industry expertise. She was most recently Vice President of Risk Management for Lundbeck, Inc. (formerly Ovation Pharmaceuticals). Prior to that, she was Vice President for International Regulatory Affairs at Ovation, where she was responsible for global pharmacovigilance.

"We are very excited to welcome Eman's leadership to the Advanced Clinical team," said Dr. Christina Fleming, Executive Vice President, Scientific and Medical Affairs. "Her high-level expertise and regulatory knowledge as well as her passion for business development and growth are a perfect fit for Advanced Clinical's goals and strategy."
Leo Sheridan, CEO of Advanced Clinical, echoes Dr. Fleming's sentiment. "We are honored to bring Eman's caliber and experience to our team. Her commitment to life sciences innovation is unparalleled, and her insight is a critical asset to the industry and our company."
Ms. Albazzaz earned her Bachelor of Science degree (with honors) in Pharmacy from Baghdad University College of Pharmacy, Baghdad, Iraq, where she also held multiple positions in teaching Pharmacology and Toxicology. She is an active member of the Drug Information Association, the Parenteral Drug Association, and the American Society of Health System Pharmacists. Ms. Albazzaz resides in the Chicagoland area and will be based out of Advanced Clinical's headquarters in Deerfield, IL.

About Advanced Clinical
Advanced Clinical provides strategic sourcing through their full-service CRO. They also provide talent management, technology solutions, and consulting services to the Life Sciences industry. With 15+ years of experience, Advanced Clinical is an established presence in the clinical research field, providing services specifically for Pharmaceutical, Biopharmaceutical, Biotechnology, and Medical Device organizations. Advanced utilizes a value-based, "One Team" approach. To learn more, visit http://www.advancedclinical.com.

Contact:
Lana Johnson
Director of Marketing
Advanced Clinical
(630) 271-8185
[email protected]
www.advancedgroup.com
Twitter: @AdvClinical

###

 

Suggested Articles

Across its 15-year history, Omega Funds has a hand in a clutch of high-profile biotechs such as Editas Medicine and Juno Therapeutics.

After Novartis’ near $10 billion buyout of The Medicines Company, many thought cardiovascular therapies were hot again.

Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.